Nancy J. Wysenski
Ms. Wysenski most recently served as the Executive Vice President and Chief Commercial Officer of Vertex Pharmaceuticals Inc. from December 2009 through June 2012. Prior to joining Vertex, she held the position of Chief Operating Officer of Endo Pharmaceuticals plc (“Endo”), where she led sales, marketing, commercial operations, supply chain management, human resources and various business development initiatives. Prior to her role at Endo, Ms. Wysenski participated in the establishment of EMD Pharmaceuticals, Inc., where she held various leadership positions, including the role of President and Chief Executive Officer from 2001 to 2006 and Vice President of Commercial from 1999 to 2001. From 1984 to 1998, Ms. Wysenski held several sales-focused roles at major pharmaceutical companies, including Vice President of Field Sales for Astra Merck, Inc. Ms. Wysenski serves on the Boards of Directors of Provention Bio, Inc. and Cytokinetics, Inc. She was previously on the Boards of Directors of Dova Pharmaceuticals Inc., Reata Pharmaceuticals, Inc., Inovio Pharmaceuticals, Inc. and Tetraphase Pharmaceuticals, Inc. She is a founder of the Research Triangle Park Chapter of the Healthcare Businesswomen’s Association and served on the Nominating Committee and National Advisory Board of the Healthcare Businesswomen’s Association.
Back to Leadership page